No abstract

The fourth chapter explains the revised model by aligning the three distinguishing characteristics of PGT with the three widely recognized components in the current model. The practice of the current model of informed consent in matters related to genetics tends to be more of an event, disclosure model.1 Tom Beauchamp explains that some technologies make it more difficult to encourage growth of both technological and patient rights.2 The new genetic technologies being developed and implemented today have many implications for informed consent that are not being adequately addressed in the current model.According to Ulrike Felt, Milena Bister, Michael Strassnig, and Ursula Wagner, if actual practices are different than what the ideal goals are, then some changes need to occur. As a result, the authors question if revising disclosure methods are the only necessary changes.3 While one of the foundations of consent is disclosing information, the revised model seeks to go further. The revised model focuses on a process approach that promotes understanding over time with assessment mechanisms. The process of consent encourages respect for persons by supporting selfdetermination for decisions. 4 To explain the significance of the revised model of consent, the following main categories of comprehension, disclosure, voluntariness, and patient safety are discussed. The first three categories will analyze both the current and revised model of informed consent for PGT, and the last category will discuss patient safety in the revised model.

No abstract

No abstract

No abstract